EricStephenWinerMD

PubMed

• Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real-world data from eig...
  Yasmin Abaza, Eric S Winer, Guru Subramanian Guru Murthy, Rory M Shallis, Andrew H Matthews, Talha Badar, Emily M Geramita, Vamsi K Kota, Alok Swaroop, Peter Doukas, D...> ;American Journal of Hematology. 2024 Apr 1
• 3 citations
  Phase 1b trial of tagraxofusp in combination with azacitidine with or without venetoclax in acute myeloid leukemia.
  Lane, A., Garcia, J., Raulston, E., Garzon, J., Galinsky, I., Baxter, E., Leonard, R., DeAngelo, D., Luskin, M., Reilly, C., Stahl, M., Stone, R., Vedula, R., Wadleigh...> ;Blood Advances. 2024 Feb 13
• Cutaneous Manifestations of Myeloid Neoplasms Exhibit Broad and Divergent Morphologic and Immunophenotypic Features but Share Ancestral Clonal Mutations With Bone Marrow.
  Sam Sadigh, Daniel J DeAngelo, Jacqueline S Garcia, Robert P Hasserjian, Christopher B Hergott, Andrew A Lane, Scott B Lovitch, Fabienne Lucas, Marlise R Luskin, Eliza...> ;Modern Pathology. 2024 Jan 1
• 1 citations
  Vemurafenib and Obinutuzumab as Frontline Therapy for Hairy Cell Leukemia.
  Jae H Park, Sean Devlin, Benjamin H Durham, Eric S Winer, Scott Huntington, Gottfried von Keudell, Shreya Vemuri, Madhulika Shukla, Victoria Falco, Bernadette Cuello, ...> ;NEJM Evidence. 2023 Oct 1
• Incidence and predictors of anthracycline-related left ventricular dysfunction in acute myeloid leukemia.
  Gerard Giblin, Yiwen Liu, Eric S Winer, Jacqueline S Garcia, Evan Chen, Martha Wadleigh, Kelly Ling, R Coleman Lindsley, Shai Shimony, Kevin Copson, Anne Charles, Dani...> ;Leukemia Research. 2023 Sep 1
• 2 citations
  FLT3-ITD does not predict inferior prognosis in acute myeloid leukemia patients aged ≥60 years.
  Shai Shimony, Geoffrey Fell, Evan C Chen, Harrison K Tsai, Martha Wadleigh, Eric S Winer, Jacqueline S Garcia, Marlise R Luskin, Donna S Neuberg, Daniel J DeAngelo, R ...> ;Blood Advances. 2023 Sep 26
• 19 citations
  Eprenetapopt combined with venetoclax and azacitidine in TP53-mutated acute myeloid leukaemia: a phase 1, dose-finding and expansion study.
  Guillermo Garcia-Manero, Aaron D Goldberg, Eric S Winer, Jessica K Altman, Amir T Fathi, Olatoyosi Odenike, Gail J Roboz, Kendra Sweet, Crystal Miller, Anders Wennborg...> ;The Lancet. Haematology. 2023 Apr 1
• Ixazomib, Oral Metronomic Cyclophosphamide, and Dexamethasone for First-Line Treatment of Multiple Myeloma: A Phase II Brown University Oncology Group Study.
  Ari Pelcovits, Peter Barth, John L Reagan, Adam J Olszewski, Vallerie Rosati, Roxanne Wood, Ashlee Sturtevant, Eric S Winer> ;The Oncologist. 2023 May 8
• Intensity of induction regimen and outcomes among adults with Ph+ALL undergoing allogeneic hematopoietic stem cell transplantation.
  Hari S Raman, Se Eun Kim, Daniel J DeAngelo, Kristen E Stevenson, Donna Neuberg, Eric S Winer, Martha Wadleigh, Jacqueline S Garcia, Annette S Kim, Richard M Stone, Vi...> ;Leukemia Research. 2023 Feb 1
• 2 citations
  Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates.
  Evan C Chen, Helen Gandler, Isidora Tošić, Geoffrey G Fell, Ashlee Fiore, Olga Pozdnyakova, Daniel J DeAngelo, Ilene Galinsky, Marlise R Luskin, Martha Wadleigh, Eric ...> ;Clinical Cancer Research. 2023 Mar 1
• 18 citations
  Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings.
  Jacqueline S Garcia, Yael Flamand, Livius Penter, Michael Keng, Benjamin K Tomlinson, Lourdes M Mendez, Paul Koller, Nicole Cullen, Yohei Arihara, Kathleen Pfaff, Jacq...> ;Blood. 2023 Apr 13
• 12 citations
  Outcomes of antifungal prophylaxis for newly diagnosed AML patients treated with a hypomethylating agent and venetoclax.
  Evan C Chen, Yiwen Liu, Courtney E Harris, Eric S Winer, Martha Wadleigh, Andrew A Lane, Rahul S Vedula, R Coleman Lindsley, Kevin M Copson, Anne Charles, Francisco Ma...> ;Leukemia & Lymphoma. 2022 Aug 1
• 10 citations
  BCOR and BCORL1 Mutations Drive Epigenetic Reprogramming and Oncogenic Signaling by Unlinking PRC1.1 from Target Genes.
  Eva J Schaefer, Helen C Wang, Hannah Q Karp, Clifford A Meyer, Paloma Cejas, Micah D Gearhart, Emmalee R Adelman, Iman Fares, Annie Apffel, Klothilda Lim, Yingtian Xie...> ;Blood Cancer Discovery. 2022 Mar 1
• 3 citations
  Transcriptional differences between JAK2-V617F and wild-type bone marrow cells in patients with myeloproliferative neoplasms.
  Debra Van Egeren, Baransel Kamaz, Shichen Liu, Maximilian Nguyen, Christopher R Reilly, Maria Kalyva, Daniel J DeAngelo, Ilene Galinsky, Martha Wadleigh, Eric S Winer,...> ;Experimental Hematology. 2022 Mar 1
• 9 citations
  Peri-transfusion quality-of-life assessment for patients with myelodysplastic syndromes
  Gregory A. Abel, Heidi D. Klepin, Emily S. Magnavita, Tim Jaung, Wen Lu, Rory M. Shallis, Andrew Hantel, Nupur E. Bahl, Rebecca Dellinger-Johnson, Eric S. Winer, Amer ...> ;Transfusion. 2021 Jul 12
• 114 citations
  Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: a phase 1 study
  Eytan M. Stein, Courtney D. DiNardo, Amir T. Fathi, Alice S. Mims, Keith W. Pratz, Michael R. Savona, Anthony S. Stein, Richard Stone, Eric S. Winer, Christopher S. Se...> ;Blood. 2021 Apr 1
• 94 citations
  Reconstructing the Lineage Histories and Differentiation Trajectories of Individual Cancer Cells in Myeloproliferative Neoplasms
  Debra Van Egeren, Javier Escabi, Maximilian Nguyen, Shichen Liu, Christopher R. Reilly, Sachin Patel, Baransel Kamaz, Maria Kalyva, Daniel J. DeAngelo, Ilene Galinsky,...> ;Cell Stem Cell. 2021 Mar 4
• 15 citations
  A dose escalation study of RO6870810/TEN-10 in patients with acute myeloid leukemia and myelodysplastic syndrome.
  Gail J. Roboz, Pinkal Desai, Sangmin Lee, Ellen K. Ritchie, Eric S. Winer, Mark DeMario, Barbara J. Brennan, Eveline Nüesch, Evelyne Chesne, Laura Brennan, Katharina L...> ;Leukemia & Lymphoma. 2021 Feb 13
• Characteristic nuclear membrane ALK reactivity in chronic myelomonocytic leukemia with RANBP2-ALK fusion.
  Christopher B. Hergott, Paola Dal Cin, Jason L. Hornick, Eric S. Winer, Ruben D. Carrasco, Annette S. Kim> ;American Journal of Hematology. 2021 Jan 25
• 21 citations
  Alisertib Plus Induction Chemotherapy in Previously Untreated Patients With High-Risk, Acute Myeloid Leukaemia: A Single-Arm, Phase 2 Trial
  Andrew M. Brunner, Traci M. Blonquist, Daniel J. DeAngelo, Malgorzata McMasters, Geoffrey Fell, Nicole M. Hermance, Eric S. Winer, R. Coleman Lindsley, Gabriela S. Hob...> ;The Lancet. Haematology. 2020 Feb 1
• 13 citations
  Secondary Acute Myeloid Leukemia: A Primary Challenge of Diagnosis and Treatment.
  Eric S. Winer> ;Hematology/oncology Clinics of North America. 2020 Jan 7
• 78 citations
  Novel therapy in Acute myeloid leukemia (AML): moving toward targeted approaches:
  Eric S. Winer, Richard Stone> ;Therapeutic Advances in Hematology. 2019 Jul 10
• 6 citations
  Multicenter, Open-Label, Phase II Study of Bendamustine and Rituximab Followed by 90-Yttrium (Y) Ibritumomab Tiuxetan for Untreated Follicular Lymphoma (Fol-BRITe)
  Frederick Lansigan, Cristiana A Costa, Bassem I. Zaki, Stephanie P. Yen, Eric S. Winer, Helen Ryan, Darcie Findley, Sara R Metzler, Lynn Shaw, Bonnie Toaso, Todd A. Ma...> ;Clinical Cancer Research. 2019 Jun 26
• 39 citations
  Clinicopathologic and genetic characterization of nonacute NPM1-mutated myeloid neoplasms
  Sanjay S. Patel, Caleb Ho, Ryan Ptashkin, Sam Sadigh, Adam Bagg, Julia T. Geyer, Mina L. Xu, Thomas Prebet, Emily F Mason, Adam C. Seegmiller, Elizabeth A. Morgan, Dav...> ;Blood Advances. 2019 May 14
• 17 citations
  Eltrombopag treatment during induction chemotherapy for acute myeloid leukaemia: a randomised, double-blind, phase 2 study.
  Noelle V. Frey, Jun Ho Jang, Jeff Szer, Árpád Illés, Hee-Je Kim, Ron Ram, Beng H. Chong, Jacob M. Rowe, Elena Borisenkova, Jane L. Liesveld, Eric S. Winer, Azzeddine C...> ;The Lancet. Haematology. 2019 Mar 1
• Join now to see all

Abstracts/Posters

• A Multicenter Phase I Study Combining Venetoclax with Mini-Hyper-CVD in Older Adults with Untreated and Relapsed/Refractory Acute Lymphoblastic Leukemia
  Eric S. Winer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Sleep Disturbance Among Patients with Myelodysplastic Syndromes and Acute Leukemia
  Eric S. Winer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Clinical and Immunologic Activity of Ipilimumab Following Decitabine Priming in Post-Allogeneic Transplant and Transplant-Na¥ve Patients with Relapsed or Refractory My...
  Eric S. Winer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical, Clinical, and Correlative Studies
  Eric S. Winer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• First Line Chemo-Free Therapy with the BRAF Inhibitor Vemurafenib Combined with Obinutuzumab Is Effective in Patients with Hcl
  Eric S. Winer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all